How are monoclonal antibodies used in infectious diseases?
Best insight from top research papers
Monoclonal antibodies (mAbs) are used in infectious diseases for both prophylaxis and therapy. They target specific epitopes of highly conserved proteins in viruses or bacteria, preventing infection or tissue damage . In the field of infectious diseases, mAbs have gained interest as a potential treatment option to combat antibiotic resistance in bacteria . Antibodies, especially monoclonal antibodies, offer rapid and specific diagnosis of microbial infections due to their target selectivity and specificity . The use of mAbs has shown promise in the diagnosis and treatment of COVID-19, with several mAbs receiving Emergency Use Authorization for outpatient treatment of mild to moderate symptoms . Overall, mAbs have demonstrated efficacy in prophylaxis, early post-exposure treatment, and as an alternative to traditional therapies in infectious diseases, including bacterial and viral infections .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| Monoclonal antibodies are used in infectious diseases for immunotherapy, vaccine development, and viral screening, as mentioned in the paper. | |
01 Jan 2022 | Monoclonal antibodies are used for rapid and specific diagnosis and therapy of microbial infections due to their target selectivity and specificity. |
| Monoclonal antibodies (mAbs) are used in infectious diseases to counteract antibiotic resistance in bacteria and provide a new treatment option. They can target bacterial pathogens and inhibit their virulence mechanisms. | |
| Monoclonal antibodies are used for prophylaxis and therapy of infectious diseases by targeting specific epitopes of viruses or bacteria to prevent infection or tissue damage. | |
| The paper mentions that monoclonal antibodies have potential therapeutic applications in infectious diseases, including the recent potential role in treating COVID-19 caused by SARS-CoV-2. |
Related Questions
Are laboratory routinely used antibodies monoclonal or polyclonal?5 answersLaboratory routinely used antibodies are primarily monoclonal antibodies (mAbs) rather than polyclonal antibodies. Monoclonal antibodies are highly specific probes that bind to a single epitope, offering advantages in terms of specificity and consistency. Monoclonal antibodies are extensively utilized in research, clinical laboratories, and industrial processes due to their ability to detect, quantitate, and localize proteins and antigens with precision. The use of therapeutic monoclonal antibodies is rapidly expanding, with around 60 approved by the FDA, impacting clinical laboratory practices significantly. Monoclonal antibody therapeutics (MATs) are increasingly affecting clinical laboratory medicine, with a focus on monitoring and detecting antidrug antibodies (ADAs) to optimize treatment outcomes. The evolution from murine to chimeric or humanized monoclonal antibodies has addressed immunologic challenges, making mAbs effective tools in diagnostic assays and therapeutic interventions.
Importance of monoclonal antibodies in healthcare?4 answersMonoclonal antibodies (mAbs) are important tools in healthcare for diagnosing and treating various diseases. They are highly specific and can target a single epitope on a virus or bacterial pathogen. In the context of the COVID-19 pandemic, mAbs have emerged as useful diagnostic and therapeutic tools, with the potential to be used in the identification of SARS-CoV-2 and as therapy agents. mAbs have demonstrated promising therapeutic potential and have become a critical part of healthcare systems, leading to a surge in regulatory approvals for their use in treating a wide range of indications. In the field of breast cancer treatment, mAbs have shown promise as targeted cancer drugs, improving clinical therapies and overall survival length for patients. However, the use of mAbs can also lead to adverse effects, such as infusion-related reactions, which require careful management and guidelines for practitioners and nurses.
Why monoclonal antibodies are so innovative?4 answersMonoclonal antibodies (mAbs) are innovative because they have revolutionized the treatment of chronic diseases and malignancies, offering a more accessible treatment option to patients. The development of hybridoma technology for producing mAbs opened up endless possibilities for research, diagnosis, and treatment of various diseases. Advanced antibody engineering techniques have been developed to enhance the innovative potential of antibodies, allowing for the production of highly specific recombinant antibodies with improved immune protective capacities. The therapeutic use of humanized mAbs has shown efficacy in selectively identifying and killing tumor cells, leading to better quality of life for cancer patients compared to traditional treatments like chemotherapy and radiation therapy. The versatility of mAbs as therapeutic agents has led to their widespread development and marketing by major pharmaceutical firms, with numerous mAb candidates currently undergoing clinical study.
What are the potential benefits of using monoclonal antibodies in therapeutic applications?5 answersMonoclonal antibodies (mAbs) have several potential benefits in therapeutic applications. They are highly specific and targeted, making them effective in treating cell-based or pathogen-related diseases, including cancer. mAbs can be mass produced and are highly specific to viral antigens, making them a promising treatment option for COVID-19. Over the years, there have been advancements in the development of different formats of human antibodies, such as single-chain variable fragments (scFv) and bispecific antibodies, expanding their therapeutic applications. mAbs have revolutionized medicinal chemistry strategy and comprise a significant portion of new drugs approved each year, with applications in oncological and immunological/infectious diseases. In the field of urologic oncology, monoclonal antibody-based immunotherapy has shown promise in selectively eliminating tumor cells and stimulating the patient's anti-tumor immune response. These benefits highlight the potential of monoclonal antibodies in providing targeted and effective treatments for various diseases.
How can monoclonal antibodies be used for cancer treatment?5 answersMonoclonal antibodies (mAbs) are valuable tools for cancer treatment due to their ability to specifically target tumor cells while minimizing damage to healthy tissues. They can be used in various therapeutic approaches, including immunotherapy and antibody-drug conjugates (ADCs). mAbs can be engineered to have high affinity for tumor-associated antigens, allowing them to bind to and attack cancer cells. In immunotherapy, mAbs can stimulate the immune system to recognize and destroy tumor cells. ADCs combine the specificity of mAbs with the cytotoxic effects of drugs, delivering potent payloads directly to cancer cells. Additionally, radiolabeled mAbs can be used for diagnostic imaging and as part of radioimmunotherapy approaches. The development of biosimilar mAbs could help reduce costs and increase access to these effective cancer treatments.
When are monoclonal antibodies most effective for Covid?6 answers